For example, FGFR1 is amplified in lung and breast cancers and rarely in pancreatic and squamous cell lung cancers, whereas FGFR2 amplification mainly occurs in gastric and breast cancers. This evidence concerns the gene FGFR1 and squamous cell lung carcinoma.